Secondary cytokines interact in sequence with interleukin-1α (IL-1α) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals

Journal of Interferon and Cytokine Research

Volumn 17, Issue 8, 1997, Pages 453-460

  Kovacs, C J ^a   Evans, M J ^a   Daly, B M ^a   Thomas Patterson, D ^a   Johnke, R M ^a   Powell, D S ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW SUPPRESSION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GRANULOCYTE; GRANULOPOIESIS; HEMATOPOIESIS; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030859286     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.453     Document Type: Article

References (45)

1. HODGSON, G.S., and BRADLEY, T.R. (1979). Properties of haematopoietic stem cell surviving 5FU treatment: evidence for a pre-CFU-S cell? Nature 281, 381-384.
2. BRADLEY, T.R., HODGSON, G.S., and BERTONCELLO, I. (1980). Characteristics of primitive macrophage progenitor cells with high proliferative potential: relationship to cells with marrow repopulating ability in 5-fluorouracil-treated mouse bone marrow. In: Experimental Hematology Today. S.G. Baum, G.D. Ledney, and D.W. Bekkum (eds.) New York: Karger, pp. 285-297.
3. McNIECE, I.K., BRADLEY, T.R., KREIGLER, A.B., and HODGSON, G.S. (1986). Subpopulations of mouse bone marrow high-proliferative potential colony-forming cells. Exp. Hematol. 14, 856-860.
4. McNIECE, I.K., BERTONCELLO, I., KRIEGLER, A.B., and QUESENBERRY, P.J. (1990). Colony-forming cells with high proliferative potential (HPP-CFC). Int. J. Cell Cloning 18, 146-160.
5. McNIECE, I.K., BERTONCELLO, I., KREIGLER, A.B., QUESENBERRY, P.J., and ZSEBO, K.M. (1992). Colony-forming cells with high proliferative potential. In Murphy MJ (ed.) In: Concise Reviews in Clinical and Experimental Hematology. M.J. Murphy (ed.) Dayton: AlphaMed Press, pp. 267-277.
6. KOVACS, C.J., HARRELL, J.P., GOOYA, J.M., EVANS, M.J., and JOHNKE, R.M. (1992). Synergy between rHuIL-1 and rHuM-CSF during the recovery of murine hematopoietic activity in myelosuppressed animals: the effect of abbreviated vs. chronic administration of rHuM-CSF. Exp. Hematol. 20, 528-589.
7. KOVACS, C.J., HARRELL, J.P., EVANS, M.J., ABERNATHY, R.S., ROBERTS, C.J., and JOHNKE, R.M. (1994). Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3), and recombinant human macrophage colony-stimulating factor (rHuM-CSF). Stem Cell 12, 103-113.
8. KOVACS, C.J., EVANS, M.J., ROBERTS, C.J., HARRELL, J., ABERNATHY, R., GOOYA, J., and JOHNKE, R.M. (1994). Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administration of IL-1 and M-CSF. Exp. Hematol. 23, 1016-1023.
9. MOORE, M.A.S., and WARREN, D.J. (1987). Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulating of stem cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc. Natl. Acad. Sci. USA 84, 7134-7138.
10. MOORE, M.A.S., WARREN, D.J., and SOUZA, L.M. (1987). Synergistic interaction between interleukin 1 and CSFs in hematopoiesis. In: UCLA Symposium on Leukemia: Recent Advances in Leukemia and Lymphoma. R.P. Gale and D.W. Golde (eds.) New York: Alan R. Liss, pp. 455-456.
11. BRADLEY, T.R., WILLIAMS, N., KRIEGLER, A.B., FAWCETT, J., and HODGSON, G.S. (1989). In vivo effects of interleukin 1 on regenerating mouse bone marrow myeloid colony-forming cells after treatment with 5-fluorouracil. Leukemia 3, 893-896.
12. SUDA, T., SUDA, J., OGAWA, M., and IHLE, J.N. (1985). Permissive role of interleukin-3 (IL-3) in proliferation and differentiation of multipotential hematopoietic progenitors in culture. J. Cell Physiol. 124, 182-189.
13. BODINE, D.M., SEIDEL, N.E., ZSEBO, K., and ORLIC, D. (1993). In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82, 445-455.
14. ULICH, T.R., DEL CASTILLO, J., and GUO, K. (1989). In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. Blood 74, 1241.
15. LORD, B.I., MOLINEU, G., TESTA, N.G., KELLY, M., SPOONCER, E., and DEXTER, T.M. (1986). The kinetic response of hematopoietic precursor cells in vivo to highly purified recombinant interleukin-3. Lymphokine Res. 5, 97-104.
16. WILLIAMS, D.E., HANGOC, G., COOPER, S., BOSWELL, H.S., SHADDUCK, R.K., GILLIS, S., WAHEED, A., URADAL, D., and BROXMEYER, H.E. (1987). The effects of purified recombinant murine interleukin-3 and or purified natural murine CSF-1 in vivo on the proliferation of murine high- and low-proliferative potential colony-forming cells: demonstration of in vivo synergy. Blood 70, 401-403.
17. TAKATSIUKI, F., OKANO, A., SUZUKI, C., MIYASAKA, Y., HIRANO, T., KISHIMOTO, T., EJIMA, D., and AKIYAMA, Y. (1990). Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment. Cancer Res. 50, 2885-2890.
18. ISHIBASHI, T., KIMURA, H., SHIKAMA, Y., UCHIDA, T., KARIONE, S., HIARANO, T., KISHIMOTO, T., TAKATSUKI, F., and AKIYAMA, Y. (1989). Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74, 1241-1244.
19. KAOYUKI, K., CLARK, S.C., and OGAWA, M. (1993). Growth factor requirements for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 81, 610-616.
20. WONG, G.G., WITEK-GIANNOTTI, J.S., TEMPLE, P.A., KRIZ, R., FERENZ, C., CLARK, S.C., IKEBUCHI, K., and OGAWA, M. (1988). Stimulation of murine hemopoietic colony formation by human IL-6. J. Immunol. 140, 3040.
21. OKADA, S., NAKAUCHI, H., NAGAYOSHI, K., NAKAMURA, M., MIURA, Y., and SUDA, T. (1992). Synergistic effect of IL-3 and IL-6 on highly enriched murine hemopoietic progenitors. Exp. Hematol. 20, 546-551.
22. RENNICK, D., JACKSON, J., YANG, G., WIDEMAN, J., LEE, F., and HUDAK, S. (1989). Interleukin 6 interacts with interleukin 4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid and multipotential progenitor cells. Blood 73, 1828-1835.
23. IKEBUCHI, K., WONG, G.C., CLARK, S.C., IHLE, J.N., HIRAI, Y., and OGAWA, M. (1987). Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 84, 9035-9039.
24. CLARK, S.C. (1989). Multiple activities in regulation of hematopoietic and immune systems. Ann. NY Acad. Sci. 55, 438-443.
25. KOIKE, K., OGAWA, M., IHLE, J.N., MIAYAKE, T., SHIMIZU, T., MIYAJIMA, A., YOKOTA, T., and ARAI, K. (1987). Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM- and multipotential blast cell colonies in culture: comparison to the effect of interleukin-3. J. Cell Physiol. 131, 458-464.
26. BROXMEYER, H.E. (1986). Biomolecule-cell interactions and the regulation of myelopoiesis. Int. J. Cell Cloning 4, 378-405.
27. WILLIAMS, E.D., PARK, L.S., and BROXMEYER, H.E. (1991). Hybrid cytokines as hematopoietic growth factors. Int. J. Cell Cloning 9, 542-547.
28. OSTER, W., and SCHULTZ, G. (1991). Interleukin 3: biological and clinical effects. Int. J. Cell Cloning 9, 5-23.
29. LEARY, A.G., YANG, Y.C., CLARK, S.C., GASSON, J.C., GOLDE, D.W., and OGAWA, M. (1987). Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 70, 1346-1348.
30. OTTMANN, O.G., ABBOUD, M., WELTE, K., SOUZA, L.M., and PELUS, L.M. (1989). Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte macrophage and granulocyte colony-stimulating factors. Exp. Hematol. 17, 191-197.
31. STAHL, C.P., WINTON, E.F., MONROE, M.C., HAFF, E., HOLMAN, R.C., MYERS, L., LIEHL, E., and EVATT, B.L. (1992). Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates. Blood 80, 2479-2485.
32. ULRICH, T.R., DEL CASTILLO, J., KEYS, M., GRANGER, G.A., and NI, R.-X. (1987). Kinetics and mechanisms of recombinant human interleukin-1 and tumor necrosis factor-induced changes in circulating number of neutrophils and lymphocytes. J. Immunol. 139, 3406-3415.
33. STORK, L.C., PETERSON, V.M., RUNDUS, C.H., and ROBINSON, W.A. (1988). Interleukin-1 enhances murine granulopoiesis in vivo. Exp. Hematol. 16, 163-167.
34. MONROY, R.L., SKELLY, R.R., DAVIS, T.A., and MACVITTIE, T.J. (1992). Therapeutic evaluation of interleukin-1 for stimulation of hematopoiesis in primates after autologous bone marrow transplantation. Biotherapy 4, 97-108.
35. IDO, M., HARADA, M., FURUICHI, H., MATSUOKA, N., and NAKANO, K. (1992). Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice. Exp. Hematol. 20, 161-166.
36. KRIEGLER, A.B., VERSCHOOR, S.M., BERNARDO, D., and BERTONCELLO, I. (1994). The relationship between different high proliferative potential colony-forming cells in the mouse bone marrow. Exp. Hematol. 22, 432-440.
37. MUENCH, M.O., SCHNEIDER, J.G., and MOORE, M.A.S. (1992). Interactions among colony-stimulating factors IL-1, IL-6 and Kit-ligand in the regulation of primitive murine hematopoietic cells. Exp. Hematol. 20, 339-349.
38. SAWANDA, K., KRANTZ, S.B., DAI, C-H., SATO, N., IEKO, M., SAKURAMA, S., YASUKOUCHI, T., and NAKAGAWA, S. (1991). Transitional change of colony-stimulating factor requirements for erythroid progenitors. J. Cell Physiol. 149, 1-8.
39. KITTLER, E.L.W., McGRATH, H., TEMELES, D., CRITTENDEN, R.B., KISTER, V.K., and QUESENBERRY, P.J. (1992). Biologic significance of constitutive and subliminal growth factor production by bone marrow stroma. Exp. Hematol. 20, 75-79.
40. GUBA, S.C., SARTOR, C.I., GOTTSCHALK, L.R., YA-HU, J., MULLIGAN, T., and EMERSON, S.G. (1992). Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, ELISA, and reverse transcriptase polymerase chain reaction. Blood 80, 1190-1198.
41. LEE, M., GEGAL, G.M., and BAGBY, G.C. (1987). Interleukin-1 induces bone marrow-derived fibroblasts to produce multilineage hematopoietic growth factors. Exp. Hematol. 15, 983-988.
42. FIBBE, W.E., VAN DAMME, D., BILLIAU, A., GOSELINI, H.M., VOOGT, P.J., VAN EDEN, R.P., ALTROCK, B.W., and FALKENBURG, J.H.F. (1988). Interleukin-1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood 71, 430-435.
43. HESTDAL, K., JACOBSEN, S.E.W., RUSCETTI, F.W., DUBOIS, C.M., LONGO, D.L., CHIZZONITE, R., OPPENHEIM, J.J., and KELLER, J.R. (1992). In vivo effect of interleukin-1α on hematopoiesis: role of colony-stimulating factor receptor modulation. Blood 80, 2486-2494.
44. DUBOIS, C.M., RUSCETTI, F.W., KELLER, J.R., OPPENHEIM, J.J., HESTDAL, K., CHIZZONITE, R., and NETA, R. (1991). In vivo interleukin-1 (IL-1) administration indirectly promotes type II IL-1 receptor expression on hematopoietic bone marrow cells: novel mechanism for the hematopoietic effects of IL-1. Blood 78, 2841-2847.
45. SHIEH, J.-H., PETERSON, R.H.F., and MOORE, M.A.S. (1991). IL-1 modulation of cytokine receptors on bone marrow cells: in vitro and in vivo studies. J. Immunol. 147, 1273-1278.